Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Cost of Revenue (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Cost of Revenue data on record, last reported at $128.6 million in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 0.94% year-over-year to $128.6 million; the TTM value through Dec 2025 reached $491.0 million, changed 0.43%, while the annual FY2025 figure was $503.3 million, 2.13% up from the prior year.
  • Cost of Revenue reached $128.6 million in Q4 2025 per PBH's latest filing, up from $122.5 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $133.2 million in Q1 2025 and bottomed at $105.3 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $121.6 million, with a median of $122.8 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: grew 17.72% in 2021, then fell 10.09% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $117.6 million in 2021, then increased by 8.05% to $127.1 million in 2022, then dropped by 1.78% to $124.8 million in 2023, then increased by 2.05% to $127.4 million in 2024, then increased by 0.94% to $128.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $128.6 million in Q4 2025, $122.5 million in Q3 2025, and $106.7 million in Q2 2025.